Market Cap

Chengdu Kanghua Biological Products Co. Ltd Market Capitalization:

CN¥6.97 Billion

CNY as of July 1, 2024

US$959.4 Million

business Chengdu Kanghua Biological Products Co. Ltd Company Profile

Chengdu Kanghua Biological Products Co. Ltd Main Stock Listing

SZSE: 300841

Market Capitalization History of Chengdu Kanghua Biological Products Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Chengdu Kanghua Biological Products Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥10.01 B -14.55%
Jan. 1, 2023 CN¥11.72 B -41.47%
Jan. 1, 2022 CN¥20.02 B -25.91%
Jan. 1, 2021 CN¥27.02 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Chengdu Kanghua Biological Products Co. Ltd Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Chengdu Kanghua Biological Products Co. Ltd has the following listings and related stock indices.


Stock: SZSE: 300841

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.